Susquehanna International Group
QTTB icon

Susquehanna International Group’s Q32 Bio QTTB Stock Holding History

Susquehanna International Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,333
Closed -$47K – 14272
2022
Q2 		$47K Sell
1,333
-1,017
-43% -$34.7K ﹤0.01% 12015
2022
Q1 		$129K Sell
2,350
-789
-25% -$49K ﹤0.01% 11714
2021
Q4 		$206K Sell
3,139
-294
-9% -$28.5K ﹤0.01% 11384
2021
Q3 		$486K Sell
3,433
-389
-10% -$49.6K ﹤0.01% 9464
2021
Q2 		$500K Sell
3,822
-3,200
-46% -$399K ﹤0.01% 9598
2021
Q1 		$1.19M Buy
7,022
+1,900
+37% +$400K ﹤0.01% 7262
2020
Q4 		$1.04M Sell
5,122
-600
-10% -$116K ﹤0.01% 6633
2020
Q3 		$1.1M Buy
5,722
+1,711
+43% +$383K ﹤0.01% 5867
2020
Q2 		$1.1M Buy
4,011
+2,517
+168% +$671K ﹤0.01% 5712
2020
Q1 		$418K Sell
1,494
-284
-16% -$87K ﹤0.01% 7316
2019
Q4 		$662K Buy
+1,778
New +$509K ﹤0.01% 6379

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $891M AUM 17.3% 1-Year Est. Return

Susquehanna International Group's QTTB Position: Q3 2025 in Review

Susquehanna International Group sold out of Q32 Bio (QTTB) in Q3 2025, closing a stake of 12,909 shares — an estimated $19.2K sold.

Susquehanna International Group first reported a position in QTTB in Q2 2019 and held it in 21 quarters. The position peaked at $2.4M in Q2 2021. 53 funds tracked by Wall St. Rank hold QTTB as of Q3 2025.

  • Susquehanna International Group reported no remaining Q32 Bio position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 12,909 Q32 Bio shares in Q3 2025, an estimated $19.2K.
  • Susquehanna International Group first reported a position in Q32 Bio in Q2 2019 and held it in 21 quarters.
  • Susquehanna International Group's Q32 Bio position peaked at $2.4M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.